Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use

References

• Bartlett G. R. Phosphorus assay in column chromatography. Journal of Biological Chemistry 1990; 234: 466–470
   Google Scholar
• Burchenal J. H., Keleher K., O'Toole T., Chisholm J. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia. Cancer Research 1977; 37: 3455–3457
   PubMed Web of Science ®Google Scholar
• Chun H., Bosl G. J., Bolbey R. B. Phase II trial of l,2-diaminocyclohexane-(4-carboxyphtlalato)platinum(II) in patients with refractory germ cell tumors. Cancer Treatment Reports 1985; 69: 459–460
   PubMedGoogle Scholar
• Cowens J. W., Kanter P., Brenner D. E., Ginsberg R., Mayer L., Bally M., Cullis P., Pavelic Z., Douglass H., Petrelli N., Karakousis C., Creaven P. J. Phase I study of doxorubicin encapsulated in liposomes. ASCO 1985; 8: 69
   Google Scholar
• Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proceedings of the National Academy of Sciences, USA 1988; 85: 6949–6953
   PubMed Web of Science ®Google Scholar
• Gabizon A., Sulkes A., Biran S., Amselem S., Barenholz Y. Liposome-associated doxorubicin (L-DOX): a clinical study with an improved preparation. ASCO 1989; 8: 64
   Google Scholar
• Kelsen D. P., Scher H., Alcock N., Leyland-Jones B., Donner A., Williams L., Greene G., Burchenal J. H., Tan C., Philips F. S., Young C. W. Phase I clinical trial and pharmacokinetics of 4′-carboxyphtalato-1,2-diamino-cyclohexaneplatinum(II). Cancer Research 1982; 42: 4831–4835
   PubMed Web of Science ®Google Scholar
• Loehrer P. J., Einhorn L. Cisplatin. Annals of Internal Medicine 1984; 100: 704–713
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Boday G. P., Frankel L. S., Mehta K. Treatment of hepatosplenic candidasis with liposomal-amphotericin B. Journal of Clinical Oncology 1987; 5: 310–317
   PubMed Web of Science ®Google Scholar
• Macquet J., Cros S., Armand J. P. Pharmacological and preclinical toxoicolog-ical studies of l,2-diaminocyclohexane(isocitrato)platinum(n). Cancer Research 1984; 44: 3736–3743
   PubMed Web of Science ®Google Scholar
• Mayer L. D., Tai L. C., Ko D.-S. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Research 1989; 49: 5922–5930
   PubMed Web of Science ®Google Scholar
• Murray J. L., Kleinerman E. S., Cunningham J. E. Phase I trial of liposomal muramyl tripeptide phosphatidyl entanolamine in cancer patients. Journal of Clinical Oncology 1989; 7: 1915–1925
   PubMed Web of Science ®Google Scholar
• Nakamoto K. Infrared and Raman Spectra of Inorganic and Coordination Compounds, 3rd edn. John Wiley & Sons, New York 1978
   Google Scholar
• Neidle S., Ismail I. M., Sadler P. J. The structure of antitumor complex cis-(diamino)(1,1-cyclobutane carboxylato) platinum(II). X-ray and NMR studies. Journal of Inorganic Biochemistry 1980; 13: 205
   Web of Science ®Google Scholar
• Patel H. M., Ryman B. E. Systemic and oral administration of liposomes. Liposomes: From Physical Structure to Therapeutic Application, X. X. Knight. Elsevier/North-Holland Biomedical Press, Amsterdam 1981; 409–441
   Google Scholar
• Perez-Soler R. Liposomes as carriers of antitumor agents: toward a clinical reality. Cancer Treatment Reviews 1989; 16: 67–82
   PubMed Web of Science ®Google Scholar
• Perez-Soler R., Khokhar A. R., Lopez-Berestein G. a, Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-l,2-diaminocyclohexaneplatinum(n) encapsulated in multilamellar vesicles. Cancer Research 1987; 47: 6462–6466
   PubMed Web of Science ®Google Scholar
• Perez-Soler R., Khokhar A. R., Lautersztain J., Mitchell P. A., Schmidt K. L. b, Ultrastructure and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. Cancer Drug Delivery 1987; 4: 75–88
   PubMedGoogle Scholar
• Perez-Soler R., Yang L. Y., Drewinko B., Lautersztain J., Khokhar A. R. Increased cytotoxicity and reversal of resistance to cis-diamminedichloroplatinum(n) with entrapment of cis-bis-neodecanoate-trans-R,R-1,2-diaminocyclohexane-platinum(n) in multilamellar lipid vesicles. Cancer Research 1988; 48: 4509–4512
   PubMed Web of Science ®Google Scholar
• Perez-Soler R., Lautersztain J., Stephens L. C., Wright K., Khokhar A. R. Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(n). Cancer Chemotherapy and Pharmacology 1989; 24: 1–8
   PubMed Web of Science ®Google Scholar
• Perez-Soler R., Lopez-Berestein G., Lautersztain J., Al-Baker S., Francis K., Macias-Kiger D., Raber M. N., Khokhar A. R. Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(n). Cancer Research 1990; 50: 4254–4259
   PubMed Web of Science ®Google Scholar
• Prestayko A. W., Bradner W. T., Huftalen J. B., Rose W. C., Schurig J. E., Cleane M. J., Hydes P. C., Crooke S. T. Antileukemic (L1210) activity and toxicity of cis-dichlorodiammine-platinum(n) analogs. Cancer Treatment Reports 1979; 63: 1503–1507
   PubMedGoogle Scholar
• Ryman B. E., Tyrell D. A. Liposomes–bags of potential. Essays in Biochemistry 1980; 16: 49–98
   PubMedGoogle Scholar
• Soulier J. P., Coune A., Meunier F., Brassinne C., Laduron C., Colette N., Meymans C., Klastersky J. Pilot study of amphotericin B entrapped into sonicated liposomes in cancer patients with mycotic complications. ASCO. 1986; 5
   Google Scholar
• Sharma D., Muggia F., Lucci L., Chan K., Forssen E., Gill P. Liposomal daunorubicin (VS 103): Tolerance and clinical effects in AIDS-related Kaposi's sarcoma (KS) during a Phase I study. Proceedings ASCO 9, 4. 1990
   Google Scholar
• Siddik Z. H., Boxall F. E., Harrap K. R. Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hymanine hydroxide. Analytical Biochemistry 1987; 163: 21–26
   PubMed Web of Science ®Google Scholar
• Stewart D. J., Leavens M., Manor M., Feun L., Luna M., Bonura J., Benjamin R. S., Caprioli R. M. Human central nervous systems distribution of cis-diamminedichloroplatinum and use as a ratiosensitizer in malignant brain tumors. Cancer Research 1982; 42: 2474–2479
   PubMed Web of Science ®Google Scholar
• Treat J., Greenspan A., Woolley P. V., Forst D., Ferrans V., Sanchez J., Rahman A. Evaluation of cardiotoxicity of liposome-encapsulated doxorubicin (LED). Proceedings ASCO 9, 71. 1990
   Google Scholar
• Weinstein J. N., Leserman L. D. Liposomes as drug carriers in cancer chemotherapy. Pharmacological Therapy 1984; 24: 207–233
   PubMed Web of Science ®Google Scholar
• Zwelling L. A., Kohn K. W. Platinum complexes. Pharmacologic Principles of Cancer Therapy, B. A. Chabner. W. B. Saunders, Philadelphia 1982; 309–338
   Google Scholar